No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Asset Management
The fund primarily aims to generate significant capital appreciation for investors over an extended timeframe. To achieve this, it commits at least 80% of its overall assets to equity instruments, predominantly common stocks, of companies engaged in the health sciences and related fields. This specialized sector encompasses a broad spectrum of businesses, such as those involved in medical equipment and supplies, healthcare service delivery, advanced biotechnology, and pharmaceutical manufacturing. The portfolio maintains a concentrated investment approach, allocating more than 25% of its holdings to these health sciences and associated industries, and it also retains the flexibility to invest in companies based outside the United States.
www.blackrock.com/us/individual/products/227451/blackrock-health-sciences-opps-class-a-fundNo one on the platform currently holds SHSAX.
No tracked institution reports a position in SHSAX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-22 | $6.4645 | 2026-07-23 |
| 2025-12-09 | $3.0469 | 2025-12-09 |
| 2025-07-17 | $3.8366 | 2025-07-17 |
| 2024-12-11 | $3.2425 | 2024-12-11 |
| 2024-07-18 | $2.4913 | 2024-07-18 |
| 2023-12-07 | $1.1709 | 2023-12-07 |
No one on the platform has traded SHSAX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| SHSAXBlackRock Health Sciences Opportunities Portfolio Investor A Shares | $63.51 | -0.11% | $6.4B | — |
| FSPHXFidelity Select Health Care Portfolio | $29.29 | +0.07% | $6.8B | — |
| LMGNXClearBridge International Growth I | $72.93 | -0.37% | $7.1B | — |
| PRPFXPermanent Portfolio Permanent I | $78.17 | +0.13% | $7.4B | — |
| RBAIXT. Rowe Price Balanced I Class | $29.93 | -0.33% | $5.3B | — |
| SHISXBlackRock Health Sciences Opportunities Portfolio Service Shares | $63.94 | -0.11% | $6.4B | — |
| SHSCXBlackRock Health Sciences Opportunities Portfolio | $47.27 | -0.11% | $6.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
The fund primarily aims to generate significant capital appreciation for investors over an extended timeframe. To achieve this, it commits at least 80% of its overall assets to equity instruments, predominantly common stocks, of companies engaged in the health sciences and related fields. This specialized sector encompasses a broad spectrum of businesses, such as those involved in medical equipment and supplies, healthcare service delivery, advanced biotechnology, and pharmaceutical manufacturing. The portfolio maintains a concentrated investment approach, allocating more than 25% of its holdings to these health sciences and associated industries, and it also retains the flexibility to invest in companies based outside the United States.